Skip to Main Content
Table 1—

Baseline characteristics of the study population

Metabolic syndrome
NoYes
n 124 103 
Male sex 88 77 
Age (years) 58 ± 10 58 ± 8 
BMI (kg/m226 ± 3 29 ± 3 
Smoking* 81 77 
Total cholesterol (mmol/l) 5.0 (4.4–5.7) 5.4 (4.7–6.2) 
Adiponectin (mg/l) 5.3 (3.7–7.5) 4.1 (3.0–6.4) 
hs-CRP (mg/l)† 2.0 (1.1–3.9) 3.2 (2.0–6.6) 
Creatinine clearance (Cockcroft) (ml/min) 79 ± 17 85 ± 17 
Fasting serum insulin (mIU/l)‡ 15 (9–24) 19 (11–35) 
Diabetes§ 40 
Glucose-lowering agents 19 
Antihypertensive drugs 21 44 
Lipid-lowering agents 48 56 
Parameters of coronary artery disease   
    Severity of coronary vessel disease‖   
        One-vessel disease 63 53 
        Two-vessel disease 30 36 
        Three-vessel disease 11 
    Degree of most severe lesion‖   
        50–90% stenosis 65 59 
        90–99% stenosis 18 17 
        100% stenosis 17 24 
    Duration angina pectoris until PTCA (years) 3 ± 5 3 ± 5 
    Previous myocardial infarction 39 50 
    Previous PTCA and/or coronary artery bypass grafting 29 31 
    Components of metabolic syndrome   
        Waist circumference (cm) 95 ± 9 101 ± 8 
        Systolic blood pressure (mmHg) 132 ± 21 140 ± 18 
        Diastolic blood pressure (mmHg) 76 ± 10 80 ± 9 
        HDL cholesterol (mmol/l) 1.15 (0.96–1.32) 0.93 (0.82–1.10) 
        Triglycerides (mmol/l) 1.38 (1.06–1.63) 2.25 (1.78–3.22) 
        Fasting serum glucose (mmol/l) 5.6 (5.2–5.9) 6.5 (5.7–8.1) 
Metabolic syndrome
NoYes
n 124 103 
Male sex 88 77 
Age (years) 58 ± 10 58 ± 8 
BMI (kg/m226 ± 3 29 ± 3 
Smoking* 81 77 
Total cholesterol (mmol/l) 5.0 (4.4–5.7) 5.4 (4.7–6.2) 
Adiponectin (mg/l) 5.3 (3.7–7.5) 4.1 (3.0–6.4) 
hs-CRP (mg/l)† 2.0 (1.1–3.9) 3.2 (2.0–6.6) 
Creatinine clearance (Cockcroft) (ml/min) 79 ± 17 85 ± 17 
Fasting serum insulin (mIU/l)‡ 15 (9–24) 19 (11–35) 
Diabetes§ 40 
Glucose-lowering agents 19 
Antihypertensive drugs 21 44 
Lipid-lowering agents 48 56 
Parameters of coronary artery disease   
    Severity of coronary vessel disease‖   
        One-vessel disease 63 53 
        Two-vessel disease 30 36 
        Three-vessel disease 11 
    Degree of most severe lesion‖   
        50–90% stenosis 65 59 
        90–99% stenosis 18 17 
        100% stenosis 17 24 
    Duration angina pectoris until PTCA (years) 3 ± 5 3 ± 5 
    Previous myocardial infarction 39 50 
    Previous PTCA and/or coronary artery bypass grafting 29 31 
    Components of metabolic syndrome   
        Waist circumference (cm) 95 ± 9 101 ± 8 
        Systolic blood pressure (mmHg) 132 ± 21 140 ± 18 
        Diastolic blood pressure (mmHg) 76 ± 10 80 ± 9 
        HDL cholesterol (mmol/l) 1.15 (0.96–1.32) 0.93 (0.82–1.10) 
        Triglycerides (mmol/l) 1.38 (1.06–1.63) 2.25 (1.78–3.22) 
        Fasting serum glucose (mmol/l) 5.6 (5.2–5.9) 6.5 (5.7–8.1) 

Data are means ± SD, median (interquartiles range), or percentages. *Still smoking, recently stopped smoking, or previously smoking; †plasma values >15 mg/l excluded from analyses; ‡patients on glucose-lowering agents excluded from analyses; §fasting serum glucose ≥7.0 mmol/l or self-reported diabetes; ‖according to pre-PTCA angiograms.

Close Modal

or Create an Account

Close Modal
Close Modal